The US Food and Drug Administration (FDA) has announced that yet another compounding pharmacy has initiated a national recall for all products manufactured at a Florida facility, explaining that an ...
Tirzepatide (Zepbound) is not in shortage for now, but the weight loss drug has remained inaccessible to people without insurance coverage who can't afford to pay out of pocket. Now, its manufacturer, ...
Eli Lilly announced that it is expanding its offerings of its hit weight loss drug Zepbound on Tuesday, a few days after the Food and Drug Administration lifted a shortage on Novo Nordisk’s Wegovy and ...
Another US-based pharmaceutical compounding pharmacy has recalled all of its products after it said they could potentially be contaminated with mold. A similar recall was initiated in 2012 by the New ...
Gifthealth will dispense the vials to patients who receive Zepbound prescriptions through a provider affiliated with Ro. Zepbound vials are a cash-pay product offered only through LillyDirect, meaning ...
FDA has cautioned about the potential danger of the compounds. This isn’t an illegal black market, though it has shades of gray. By Arthur Allen/KFF Health News Published Jul 25, 2024 8:00 AM EDT This ...
Inside the pharmacy at Seattle Cancer Care Alliance (SCCA), the latest and greatest in technology is on display as two new robots compound the life-saving but hazardous drugs often used to treat ...
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results